E. V. Gaydukova

E. V. Gaydukova

Auto-generated profile, based on publicly available information

E. V. Gaydukova

Burdenko Main Military Clinical Hospital, Ministry of Defense of Russia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2021 in Radiology - Practice
Verified
Journal Article
Open access
PDF file
ATA. A. Trefilov
A. A. Trefilov
EKE. V. Kryukov
E. V. Kryukov
VTV. N. Troyan
V. N. Troyan
STS. V. Tereshhuk
S. V. Tereshhuk
VSV. A. Suharev
V. A. Suharev
EGE. V. Gaydukova
E. V. Gaydukova
In this work a comparative analysis of the possibilities and efficiency of lower extremities perforator vessels visualization using the methods of Doppler ultrasound (DUS) and computed tomographic angiography (CTA) is carried out. As a result, it is shown that DUS has a number of advantages over CTA, allowing to obtain a clearer image of perforator vessels, to determine the exact location of their anatomical localization.

26 December 2023 in Kardiologiia
Verified
Journal Article
Open access
PDF file
LSL. V. Shulzhenko
L. V. Shulzhenko
IPI. V. Pershukov
I. V. Pershukov
TBT. A. Batyraliev
T. A. Batyraliev
ZKZ. A. Karben
Z. A. Karben
OGO. V. Gurovich
O. V. Gurovich
EGE. V. Gaydukova
E. V. Gaydukova
Aim A 12-month evaluation of the potentialities of the angiotensin II receptor inhibitor olmesartan (Olme) and the angiotensin receptor and neprilysin inhibitor (ARNI) sacubitril/valsartan in patients with arterial hypertension (AH) and dyslipidemia in the dynamics of the following indicators of chronic heart failure (CHF): N-terminal pro-brain natriuretic peptide (NT-proBNP), left ventricular ejection fraction (LVEF), LV global longitudinal strain (LV GLS) in diffuse myocardial fibrosis (MF) previously diagnosed by magnetic resonance imaging (MRI). Material and methods Olmesartan medoxomil (n=56) and sacubitril/valsartan (n=63) were used for 12 months in patients with hypertension, dyslipidemia and NYHA functional class II-III CHF with mid-range LVEF (CHFmrEF). MF was diagnosed by the following MRI criteria: late gadolinium enhancement and an increased proportion of extracellular matrix (33% or more). The frequency of persisting late gadolinium enhancement and the increased proportion of extracellular matrix (33% or more) was evaluated at 12 months; changes in systolic blood pressure (SBP), diastolic blood pressure (DBP), NT-proBNP, and LV GLS were evaluated after 3, 6, and 12 months of follow-up. Results Baseline parameters did not differ between groups. The late gadolinium enhancement and increased proportion of extracellular matrix were present at baseline in all patients of both groups (100%; p=1.0). Already at 3 months, statistically significant decreases in SBP and DBP were observed in both groups. In addition, the LV GLS monitoring showed LV GLS significantly increased in both groups after 3 months and continued changing after 6 and 12 months. The NT-proBNP concentration significantly decreased in both groups already after 3 months and continued to decrease after 6 and 12 months. At 6 and 12 months, sacubitril/valsartan was superior to olmesartan in reducing SBP and NT-proBNP and in restoring LV GLS. At 12 months, the incidence of persisting, abnormal late gadolinium enhancement and increased proportion of extracellular matrix was significantly less in the ARNI group. Conclusion Olmesartan was demonstrated effective in the multi-modality therapy of CHFmrEF and MF in patients with AH and dyslipidemia. ARNI was superior to olmesartan in this regard, but further research of this issue is required.

28 December 2021 in Radiology - Practice
Verified
Journal Article
Open access
PDF file
ATA. A. Trefilov
A. A. Trefilov
EKE. V. Kryukov
E. V. Kryukov
VTV. N. Troyan
V. N. Troyan
STS. V. Tereshchuk
S. V. Tereshchuk
VSV. A. Suharev
V. A. Suharev
EGE. V. Gaydukova
E. V. Gaydukova
The study describes a clinical case of preoperative planning of an anterolateral femur perforator flap and a peroneal autograft to eliminate a maxillofacial defect. During preparation for the surgery, an anatomical feature of the structure of both extremities circulatory system was found, which did not allow full use of the donor area tissues for subsequent surgical intervention. This feature was identified by Doppler ultrasound, but the final picture became clear only due to the study by computed tomography angiography.

24 August 2022 in Radiology - Practice
Verified
Journal Article
Open access
PDF file
ATA. A. Trefilov
A. A. Trefilov
EKE. V. Kryukov
E. V. Kryukov
VTV. N. Troyan
V. N. Troyan
STS. V. Tereshchuk
S. V. Tereshchuk
VSV. A. Suharev
V. A. Suharev
EGE. V. Gajdukova
E. V. Gajdukova
Preoperative detection of perforator vessels in the perforator flap planning is an actual problem in clinical practice. There are various methods to visualize the localization of perforator vessels. This review presents the main of these methods with a description of their capabilities, advantages and limitations, as well as describes the priorities for using one or another approach depending on the localization of the donor site.